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Abstract: Selective functionalization at the α-methyl group of 1-substituted pyridin-2(1H)- and 4(1H)-ones (2- and 4-pyridones) can 
be achieved by appropriate choice of base. n-Butyllithium was found to effect clean 6(2)-methyl deprotonation of 1-benzyl 2- and 4-
pyridone derivatives, while potassium hexamethyldisilazide (KHMDS) was the preferred reagent for methyl deprotonation of the 
corresponding 1-methyl 2- and 4-pyridones. Deprotonation proceeds smoothly at -78 °C and the resulting anions react readily with 
a wide range of electrophiles (aldehydes, ketones, alkylating reagents, and an azo compound) under precise temperature control to 
form usefully functionalized 2- and 4-pyridones and quinolizinones. 
 
Introduction 
 
1(N)-Substituted 2(1H)- and 4(1H)-pyridinones (commonly referred to as 2- and 4-pyridones) are widely employed in 
medicinal chemistry,[1] occur as key fragments of natural products[2] and as hydrogen bonding synthons in supramolecular 
chemistry.[3] Pyridones are regarded as privileged heterocyclic scaffolds,[4] and both synthesis and functionalization of the pyridone 
ring system continue as intensive areas of research.[5]   
Recently, CH activation of pyridones (Figure 1) has been highlighted employing Ni, Pd or Fe catalysis.[6] In this 
communication we wish to report an alternative approach for side chain functionalization of N-alkyl 2- and 4-pyridones by selective 
deprotonation of a 6- or 2-methyl substituent, along with convenient methods for the preparation of the required N-alkyl 6-methyl-2- 
and 2-methyl-4-pyridone substrates. 
 
 
 
 
Figure 1. Functionalization of pyridone scaffolds.[6] 
 
Methyl substituted 2- and 4-pyridones represent versatile building blocks for elaboration to side chain functionalized 
derivatives, and for construction of quinolizinones, bridgehead nitrogen compounds of significant recent interest as bicyclic 
scaffolds in medicinal chemistry.[7] While the addition of electrophiles to lithiated methyl pyridines continues to be studied in depth,[8] 
there is a lack of information on reactions of metalated 6-methyl-2- and 2-methyl-4-pyridones. Only limited examples of alkylation of 
2-pyridone methyl substituents are reported in the literature,[9] along with early pioneering work on ring and N-substituent 
lithiation.[10] A heterocyclic methyl group represents a source of diversity for ring functionalization,[11] while conditions to selectively 
effect lithiation of a pyridine ring, but leaving a methyl substituent intact, have also been developed.[12] Metalation of a methyl 
substituent on the weakly aromatic pyridone system thus represents a significant challenge in synthetic carbanion chemistry. Here 
we report the successful methyl deprotonation of a range of 6-methylpyridin-2(1H)- and 2-methylpyridin-4(1H)-ones, and reaction 
with a variety of electrophiles, including aldehydes, ketones, diketones, alkylating reagents and an azo compound to form highly 
functionalized pyridone derivatives relevant to medicinal chemistry. Careful choice of base and temperature control allows excellent 
regioselectivity and clean product formation in moderate to excellent isolated yield. 
 
Results and Discussion 
 
Our study started with the synthesis of the required 1-substituted 6-methylpyridin-2-ones 2a-g (Scheme 1) via direct 
alkylation of 2-methoxy-6-methylpyridine 1 adapting a method for 2-methoxypyridine.[13] Reaction with alkyl bromides proceeded in 
good to excellent yield in the absence of solvent, despite the ring nitrogen being flanked on both sides by the methoxy and methyl 
substituents. 
 
 
 
 
 
Scheme 1. Synthesis of 2-pyridone precursors 
 
Demethylation occurred concomitantly, presumably by attack by bromide ion and loss of the volatile MeBr, generating the 
1-substituted pyridones 2a-g. We were also able to generate a 1:1 mixture of 1,6-dimethyl pyridine-2(1H)-one 2a and 1-benzyl-6-
methylpyridin-2(1H)-one 2e by treating 1 with 0.5 equivalents of benzyl bromide. The two compounds could be separated readily by 
chromatography. N-Alkylation-O-dealkylation is an effective method for conversion of alkoxypyridines to pyridones[14] and avoids 
the frequent heteroatom selectivity problem associated with attempts to alkylate ambident pyridones.[15]  
With the 2-pyridone derivatives 2a-g in hand, we studied the deprotonation of the 6-methyl substituent to synthesize new 
N-alkyl-6-substituted 2-pyridones. Initially we focused on 2a and 2e as test compounds and a study of reactivity towards n-BuLi was 
undertaken (Scheme 2). 1-Benzyl-6-methyl-2-pyridone 2e was treated with n-BuLi in THF at –78 °C → 0 °C → –78 °C resulting in 
an intense blue solution. Quenching the mixture with D2O at –78 °C led to clean recovery of the mono-deuterated pyridone 3a 
(>98% by NMR; 87% isolated) substituted on the methyl group (C-7 position). The location of the label was established by 1H and 
13C NMR spectroscopy [(δH 2.23 (2H, bs) and δC 19.6 (t, 1JCD = 20 Hz)]. Treatment of 1,6-dimethyl-2-pyridone 2a with 1 equivalent 
of n-BuLi under the same conditions however, resulted in formation of an orange solution, and quenching with D2O at –78 °C 
produced a mixture of starting material and inseparable products. 
 
 
 
 
 
Scheme 2. Lithiation of 1-benzyl 2-pyridones  
 
Treatment of pyridone 2a with KHMDS as base, led to clean formation of the monodeuterated pyridone (98% by NMR; 
55% isolated), with no by-product formation. In the subsequent experiments with 2a, we thus chose to employ KHMDS as base, 
since n-BuLi appeared to attack the unhindered pyridone ring. The lithiated benzyl 2-pyridones 2e and 2f were then exposed to a 
range of electrophiles at –78 °C to produce compounds 3b-o (Figure 2). Subsequent optimization steps demonstrated that the best 
yields for direct methyl alkylation of the 1-benzyl-6-methyl-2-pyridone anion occurred with 1 eq. of n-BuLi. Use of 1.2 → 2 eq. 
afforded products in which the benzylic position was also alkylated, as observed by Katritzky.[10b,c] Pleasingly, the conditions 
developed operated effectively for all electrophiles tested (aldehyde, ketone, diketone, ketoester, alkylating agent, azo compound) 
possessing a range of functionality, proceeding in general in high yield with few exceptions. In the synthesis of pyridone 3k, the low 
yield of 19% was attributed to the poor solubility of the dibromobenzil electrophile, while addition of an unsaturated aldehyde gave a 
33% yield of 3d together with a low yield of the unstable 3e formed by conjugate addition. In an attempt to synthesize pyridone 3f, 
with propionaldehyde as electrophile, a 26% yield of the ring alkylated product 4 (addition at C-3) was obtained, together with 
starting material, as the pyridone anion was basic enough to deprotonate the α position of the aldehyde.  
 
 
 
Figure 2. Functionalized 1-benzyl 2-pyridones prepared. 
 
In studying the reactivity of the 1,6-dimethylpyridin-2(1H)-one 2a, deprotonation took place efficiently when KHMDS was 
used as base (Scheme 3). To exploit the methyl anion of the pyridone synthetically we employed aldehyde, ketone, and alkylating 
agents as electrophiles. The reactions, forming compounds 5a-5e, occurred in good to excellent yield, except when 5-bromo-1-
pentene was used. Due to its low reactivity, reaction at –78 °C or –35 °C returned only starting material, while reaction with 2.5 eq. 
of base and electrophile addition at 0 °C afforded the ring alkylated (5f; E=1-penten-5-yl, 8%), dialkylated (5g; 8%) and methyl 
dialkylated (5h; 18%) pyridones. Use of 1.0 eq. of base and electrophile addition at –10 °C was required to form the desired 
product 5d cleanly with isolation in a low 20% yield, as found by Sammes[9] who obtained 6.6% yield operating at –23 °C. In 
comparison, 5a and 5b were obtained in significantly lower yields of 37% and 38% respectively when n-BuLi was employed as 
base. 
 The next part of the study investigated methyl deprotonation of the corresponding 1-alkyl 2-methylpyridin-4(1H)-one 
derivatives. These were considered more challenging substrates due to the high polarity of the 4-pyridone system (dipole moment ≥ 
7.3 D for N-alkyl derivatives[16]  compared with ~ 4.0 for 2-pyridones.[17] 4-Pyridones are more susceptible to attack by 
nucleophiles,[18] which could compete with metalation. The higher polarity also resulted in lower isolated yields due to difficult 
extraction and chromatography. The substrates 9a and 9b were prepared by alkylation of 2-methyl-4-alkoxypyridines (Scheme 4). 
 
 
 
Scheme 3. Functionalization of pyridinone 2a 
 
 
Figure 3. X-ray crystal structure of 5e[19] 
 
 
The 4-benzyloxy derivative 7 was easily prepared by SNAr reaction of 4-chloropyridine 6, using NaH in DMSO.   
 
 
 
Scheme 4. Synthesis of 4-pyridones. 
 
Base catalyzed hydrolysis (NaOH/H2O/THF) of the resulting N-methyl and N-benzyl pyridinium salts was found a 
convenient method of conversion to the pyridones, as the salts were easily isolated by precipitation, and did not undergo 
dealkylation as had occurred in the 2-pyridone series under solvent-free conditions. 
The 1-benzyl 4-pyridone 9b was investigated first, and found to behave well using the lithiation conditions developed for benzyl 2-
pyridones (Scheme 5). Clean reaction was observed using n-BuLi, although isolated yields were only moderate. The methyl-
lithiated 9b reacted successfully with aldehyde, diketone, allyl halide and azo electrophiles forming 10a-d.  
 
 
 
Scheme 5. Functionalization of 4-pyridinone derivatives 
 
 Attempts to mono-metalate the 1,2-dimethylpyridin-4(1H)-one analogue 9a met initially with less success. Different 
reaction conditions were therefore systematically investigated in order to find a set of conditions that would favour mono-alkylation. 
The standard conditions of 1 eq. of KHMDS at –78 °C, warming to 0 °C, and quenching with the electrophile at –78 °C, 
unfortunately gave no alkylated pyridone. Screening the quantity of base from 1 to 2.5 equiv. was studied, while the temperature of 
the electrophile addition (–78 °C) and reaction time of 2 h were held constant, but again only a high recovery of starting material 
was obtained. Only by adding 2.5 equiv. of base to the pyridone at –78 °C, equilibrating to 0 °C, and electrophile addition at 0 °C (2 
h) could alkylated products be obtained with a limited range of electrophiles. Reaction with pivaldehyde was found to proceed well 
giving pyridone 11a in a moderate 15% yield. Isolation of the unsaturated product 11b (17%) formed by elimination, indicated a 
greater degree of alkylation. Use of allyl bromide gave a low yield (10%) of alkylated pyridone 11c, but the reaction was 
complicated by the subsequent deprotonation of the product, leading to further alkylation, delivering the dialkylated compound 11d 
in 39% yield. Although the yields were modest, we have demonstrated it is possible to successfully manipulate the sensitive 4-
pyridone anion in a synthetically useful way. 
Finally, we investigated the metalation reaction as a method to form quinolizinone derivatives, compounds of interest as 
bicyclic drug scaffolds.[7] As shown in Scheme 6, we were able to generate this ring system using the chemistry developed giving 
bicyclic heterocycles in modest yield. Treatment of pyridone 2c with KHMDS and reaction with 4,4’-dimethylbenzil gave 12 (10%) in 
which the ester group was lost. Addition of 1 eq. of n-BuLi, and adding the electrophile at –78 C, gave 13 showing the N-substituent 
was alkylated prior to the methyl. Use of LDA to deprotonate benzyl pyridone 2e gave 14 in low yield together with 15, also 
indicating lithiation of the N-alkyl group occurs first with this base.[10b]  
 
 
 
 
Scheme 6. Formation of quinolizinone scaffolds. 
 
Quenching the reaction at low temperature allowed isolation of the diol 16. Treatment of the preformed keto-alcohols 3i,j,l with 2 
eq. of n-BuLi gave modest yields of the quinolizinones 16-18. Dehydration to the fully unsaturated ring system did not occur under 
the reaction conditions, but 16 and 17 could be converted to quinolizinone 19 and the 6,7-dihydro compound 20 on heating with 
pTSA. 
 
Conclusions 
 
In conclusion we have optimised deprotonation conditions for the selective methyl activation of 6-methylpyridin-2(1H)-
ones and 2-methylpyridin-4(1H)-ones, and demonstrated these intermediates can be manipulated in a synthetically useful way to 
prepare side-chain functionalized pyridones and quinolizinones, important scaffolds in medicinal chemistry. n-BuLi is a suitable 
base for N-benzyl substituted pyridones, while KHMDS is preferable for N-methyl analogues. 
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